The global alopecia treatments market is anticipated to show an impressive growth in the forecast period, 2023-2027. The market is expected to show growth on the account of growing instances of hair loss among the widespread population. Lifestyle changes, and rising research and development in the alopecia treatment is driving the growth of the market in the next five years.
Number of patients suffering from alopecia is increasing rapidly and this has stirred up a demand in the effective treatment for alopecia, thereby sustaining the growth of the global alopecia treatments market in the next five years.
Also, pharmaceutical industry has been developing with effective drugs and therapeutics and various research and studies are also supporting the growth of the global alopecia treatment market in the forecast years, until 2027.
Furthermore, geriatric population is more susceptible to the disorder and since the geriatric population is increasing, the market is anticipated to grow along with it. Hormonal imbalance among the young generation due to unhealthy habits and increased alcoholism and smoking habits is making young generation rapidly struggle with loss of hair thereby supporting the growth of the global alopecia treatment market in the next five years.
The global alopecia treatment market is segmented by disease type, gender, route of administration, end user, distribution channel, competitional landscape, and regional distribution. Based on disease type, the market is further segmented into androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis. Androgenic alopecia is anticipated to hold the largest share of the market on the grounds of rising incidences of the disease along with hormonal imbalances that often happens when the person reaches geriatric age.
Along with the unhealthy lifestyle, changing habits have rendered the prevalence of the disease in the last five years, thus the segment is expected to grow further too. Also, alopecia totalis is the fastest growing market segment with the impressive CAGR owing its growth to the rising incidences of the disease and surge in the awareness among the patients and potential patients at the risk.
Major companies operating in the market are Aclaris Therapeutics Inc., Concert Pharmaceuticals Inc., Daiichi Sankyo Inc., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Sun Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Histogen Inc, Pfizer Inc., Eli Lilly and Company Ltd., Bioniz Therapeutics Inc., Reistone Biopharma Company Limited, among others.
Market players are focused on the advanced therapeutic availability along with the technologically advanced methods of the treatment applications. Other strategies considered are positive and prolonged partnerships for consistent distribution and supply of the related products.
Objective of the Study
- To analyze the historical growth in the market size of global alopecia treatments market from 2017 to 2021.
- To estimate and forecast the market size of global alopecia treatments market from 2022 to 2027 and growth rate until 2027.
- To classify and forecast global alopecia treatments market based on disease type, gender, route of administration, end user, distribution channel, regional distribution, and competitional landscape.
- To identify dominant region or segment in the global alopecia treatments market.
- To identify drivers and challenges for global alopecia treatments market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global alopecia treatments market.
- To identify and analyze the profile of leading players operating in global alopecia treatments market.
- To identify key sustainable strategies adopted by market players in global alopecia treatments market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of global alopecia treatments market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience
- Manufacturers, end users, service providers and other stakeholders
- Distributers and suppliers of products and other stakeholders
- Organizations, forums, and alliances related to alopecia treatments
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historical Years | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million and CAGR for 2017-2021 and 2022-2027 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | - Disease Type
- Gender
- Route of Administration
- End User
- Distribution Channel
|
| Regional Scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
| Country Scope | United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa |
| Key Companies Profiled | Aclaris Therapeutics Inc., Concert Pharmaceuticals Inc., Daiichi Sankyo Inc., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Sun Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Histogen Inc, Pfizer Inc., Eli Lilly and Company Ltd., Bioniz Therapeutics Inc., Reistone Biopharma Company Limited. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
